Communication & Marketing Manager
Nathalie Sablon
Send email now
On August 2017, Bertin Pharma has signed an agreement for the sale of its pre-clinical and clinical studies’ activities. CNIM Group, Bertin Pharma’s main shareholder, decided to focus on its strategic product ranges: providing Bioreagents & Bioanalytic Tools. Those markets are more in tune with its industrial core activities in the fields of energy, environment, defense and security.
Nuclear Receptor Assay kits now available in Europe for Discovery and Toxicology dedicated to over 20 Disease States such as Cardiovascular Disease, Metabolic Disease, or even Endocrinology
The CEO of Bertin Pharma, specialty CRO and supplier of products for R&D in the Life Sciences, participates from now on in the work of the Physical & Chemical Sciences section.
Co-founder of AFSSI (Association Française des Sociétés de Services et d’Innovation), Xavier Morge () intends now to enhance its visibility in France and internationally
Bertin Pharma and LXRepair sign up an agreement for manufacturing and distributing a kit to quantify DNA repair enzyme activities: Glyco-SPOT DNA Repair Assay kit
Bertin Pharma reiterates its top position in the categories "regulatory affairs" and "productivity" in the survey conducted by the company Nice Insight.
FRONTIERS IN NEUROSCIENCE - April 2017
PLOS ONE - October 2015
PLOS ONE - October 2015
My account